Journal article icon

Journal article

Hypoxia- and Postirradiation reoxygenation-induced HMHA1/ARHGAP45 expression contributes to cancer cell invasion in a HIF-dependent manner

Abstract:
Background: Cancer cells in severely hypoxic regions have been reported to invade towards tumour blood vessels after surviving radiotherapy in a postirradiation reoxygenation- and hypoxia-inducible factor (HIF)-dependent manner and cause recurrence. However, how HIF induces invasiveness of irradiated and reoxygenated cancer cells remains unclear. Methods: Here, we identified human minor histocompatibility antigen 1 (HMHA1), which has been suggested to function in cytoskeleton dynamics and cellular motility, as a responsible factor and elucidated its mechanism of action using molecular and cellular biology techniques. Results: HMHA1 expression was found to be induced at the transcription initiation level in a HIF-dependent manner under hypoxia. Boyden chamber invasion assay revealed that the induction of HMHA1 expression is required for the increase in invasion of hypoxic cancer cells. Reoxygenation treatment after ionising radiation in vitro that mimics dynamic changes of a microenvironment in hypoxic regions of tumour tissues after radiation therapy further enhanced HMHA1 expression and invasive potential of HMHA1 wildtype cancer cells in ROS- and HIF-dependent manners, but not of HMHA1 knockout cells. Conclusion: These results together provide insights into a potential molecular mechanism of the acquisition of invasiveness by hypoxic cancer cells after radiotherapy via the activation of the ROS/HIF/HMHA1 axis.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/s41416-024-02691-x

Authors


More by this author
Institution:
University of Oxford
Role:
Author


More from this funder
Funder identifier:
https://ror.org/01nmpj461
More from this funder
Funder identifier:
https://ror.org/02qjq5342
More from this funder
Funder identifier:
https://ror.org/05j492n53
More from this funder
Funder identifier:
https://ror.org/029aqdy80
More from this funder
Funder identifier:
https://ror.org/00q3q5393


Publisher:
Springer Nature [academic journals on nature.com]
Journal:
British Journal of Cancer More from this journal
Volume:
131
Issue:
1
Pages:
37-48
Publication date:
2024-05-13
Acceptance date:
2024-04-10
DOI:
EISSN:
1532-1827
ISSN:
0007-0920


Language:
English
Pubs id:
1997973
Local pid:
pubs:1997973
Source identifiers:
2095659
Deposit date:
2024-07-08
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP